Status:
UNKNOWN
DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry
Lead Sponsor:
Osprey Medical, Inc
Conditions:
Patients at Risk for Developing Contrast-induced Nephropathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry-based study is to evaluate the ongoing, real-world clinical performance and safety of commercially available DyeVert Systems during typical clinical use for patients under...
Detailed Description
Contrast-induced acute kidney injury (CI-AKI) occurs in 3-19% of patients undergoing coronary angiography and is associated with increased morbidity, mortality, and healthcare costs. Patients with chr...
Eligibility Criteria
Inclusion
- DyeVert Group Patients: Patient underwent a diagnostic and/or interventional angiography procedure in which the DyeVert System was used in a majority of the case
- Patient is willing and able to provide appropriate informed consent (if required)
Exclusion
- Required data was not collected or is not available
- In the Investigator or Sponsor's opinion, the patient is not considered to be suitable
Key Trial Info
Start Date :
May 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03825094
Start Date
May 7 2019
End Date
December 1 2023
Last Update
April 18 2022
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Healthcare
Hartford, Connecticut, United States, 06102
2
Steward Palmetto General Hospital
Hialeah, Florida, United States, 33016
3
Emory Healthcare
Atlanta, Georgia, United States, 30322
4
Atlanta VA Medical Center
Decatur, Georgia, United States, 30033